Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (141) 141
index medicus (122) 122
oncology (88) 88
male (83) 83
middle aged (81) 81
female (80) 80
hematology (78) 78
aged (75) 75
rituximab (69) 69
adult (63) 63
antineoplastic combined chemotherapy protocols - therapeutic use (60) 60
treatment outcome (54) 54
aged, 80 and over (50) 50
article (44) 44
lymphomas (43) 43
chemotherapy (39) 39
cancer (34) 34
non-hodgkins-lymphoma (31) 31
survival (31) 31
hemic and lymphatic diseases (29) 29
abridged index medicus (28) 28
prognosis (28) 28
therapy (28) 28
antineoplastic agents - therapeutic use (27) 27
disease-free survival (27) 27
care and treatment (26) 26
transplantation (24) 24
vincristine - administration & dosage (23) 23
doxorubicin - administration & dosage (22) 22
bortezomib (21) 21
cyclophosphamide - administration & dosage (21) 21
mantle cell lymphoma (21) 21
lymphoma, mantle-cell - drug therapy (20) 20
bendamustine (19) 19
prednisone - administration & dosage (19) 19
antibodies, monoclonal, murine-derived - administration & dosage (18) 18
antineoplastic combined chemotherapy protocols - administration & dosage (18) 18
follicular lymphoma (18) 18
immune system diseases (18) 18
neoplasm staging (18) 18
phase-ii (18) 18
trial (18) 18
antibodies, monoclonal, murine-derived - therapeutic use (17) 17
clinical trials (16) 16
clinical trials as topic (16) 16
immunotherapy (16) 16
lymphoma, large b-cell, diffuse - drug therapy (16) 16
lymphoma, mantle-cell - therapy (16) 16
non-hodgkin-lymphoma (16) 16
plus rituximab (16) 16
progression-free survival (16) 16
research (16) 16
young adult (16) 16
adolescent (15) 15
chronic lymphocytic-leukemia (15) 15
lymphoma (15) 15
lymphoma, mantle-cell - pathology (15) 15
survival rate (15) 15
antineoplastic agents - adverse effects (14) 14
cyclophosphamide (14) 14
doxorubicin - therapeutic use (14) 14
patients (14) 14
analysis (13) 13
antineoplastic combined chemotherapy protocols - adverse effects (13) 13
doxorubicin (13) 13
expression (13) 13
multicenter (13) 13
recurrence (13) 13
survival analysis (13) 13
vincristine (13) 13
antibodies, monoclonal - therapeutic use (12) 12
antineoplastic agents - administration & dosage (12) 12
b-cell lymphoma (12) 12
drug therapy (12) 12
follow-up studies (12) 12
lymphoma, follicular - drug therapy (12) 12
lymphoma, non-hodgkin - drug therapy (12) 12
non-hodgkin lymphoma (12) 12
vincristine - therapeutic use (12) 12
cyclophosphamide - therapeutic use (11) 11
disease (11) 11
drug administration schedule (11) 11
kaplan-meier estimate (11) 11
lymphoma, mantle-cell - mortality (11) 11
prednisone - therapeutic use (11) 11
r-chop (11) 11
clinical trials and observations (10) 10
combined modality therapy (10) 10
dose-response relationship, drug (10) 10
elderly-patients (10) 10
etoposide - administration & dosage (10) 10
hematology, oncology and palliative medicine (10) 10
hodgkin disease - drug therapy (10) 10
leukemia (10) 10
leukemia, lymphocytic, chronic, b-cell - drug therapy (10) 10
open-label (10) 10
remission induction (10) 10
risk factors (10) 10
antibodies, monoclonal, murine-derived - adverse effects (9) 9
apoptosis (9) 9
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Follicular lymphoma: Are we ready for a risk-adapted approach?
by Kahl, Brad S
Hematology, ISSN 1520-4391, 12/2017, Volume 2017, Issue 1, pp. 358 - 364
Follicular lymphoma is the most common indolent non-Hodgkin lymphoma in the Western hemisphere. The natural history of FL appears to have been favorably... 
How Understanding Disease Biology Is Influencing Clinical Decision-Making | Indolent Lymphoma
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Loncastuximab tesirine in patients with B-cell non-Hodgkin lymphoma
by Kahl, Brad S and Kahl, Brad S
Clinical advances in hematology & oncology : H&O, ISSN 1543-0790, 11/2018, Volume 16, Issue 11, pp. 732 - 734
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text With a little help from my friends
by Kahl, Brad S
Clinical Advances in Hematology and Oncology, ISSN 1543-0790, 12/2018, Volume 16, Issue 12, p. 776
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text On relevance
by Kahl, Brad S
Clinical Advances in Hematology and Oncology, ISSN 1543-0790, 10/2018, Volume 16, Issue 10, p. 634
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text The fast-changing world of CLL
by Kahl, Brad S
Clinical Advances in Hematology and Oncology, ISSN 1543-0790, 06/2018, Volume 16, Issue 6, p. 396
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text More CRO fun
by Kahl, Brad S
Clinical Advances in Hematology and Oncology, ISSN 1543-0790, 05/2018, Volume 16, Issue 5, p. 304
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Mentoring
by Kahl, Brad S
Clinical Advances in Hematology and Oncology, ISSN 1543-0790, 04/2018, Volume 16, Issue 4, p. 234
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Trivia night
by Kahl, Brad S
Clinical Advances in Hematology and Oncology, ISSN 1543-0790, 03/2018, Volume 16, Issue 3, p. 159
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Narcissist-in-chief
by Kahl, Brad S
Clinical Advances in Hematology and Oncology, ISSN 1543-0790, 02/2018, Volume 16, Issue 2, p. 74
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Another plenary, more uncertainty
by Kahl, Brad S
Clinical Advances in Hematology and Oncology, ISSN 1543-0790, 01/2018, Volume 16, Issue 1, p. 6
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Protests
by Kahl, Brad S
Clinical Advances in Hematology and Oncology, ISSN 1543-0790, 12/2017, Volume 15, Issue 12, p. 892
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Letter From the Editor: Protests
by Kahl, Brad S
Clinical advances in hematology & oncology : H&O, ISSN 1543-0790, 12/2017, Volume 15, Issue 12, p. 892
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text In memory of Oliver press, MD. PhD
by Kahl, Brad S
Clinical Advances in Hematology and Oncology, ISSN 1543-0790, 11/2017, Volume 15, Issue 11, p. 806
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Letter from the Editor: In memory of Oliver Press, MD, PhD
by Kahl, Brad S
Clinical advances in hematology & oncology : H&O, ISSN 1543-0790, 11/2017, Volume 15, Issue 11, p. 806
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text Letter from the Editor: How to treat Hodgkin lymphoma
by Kahl, Brad S
Clinical advances in hematology & oncology : H&O, ISSN 1543-0790, 10/2017, Volume 15, Issue 10, p. 722
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
16. Full Text Book club: The Panama canal
by Kahl, Brad S
Clinical Advances in Hematology and Oncology, ISSN 1543-0790, 09/2017, Volume 15, Issue 9, p. 651
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
17. Full Text Letter From the Editor: Book club: the Panama Canal
by Kahl, Brad S
Clinical advances in hematology & oncology : H&O, ISSN 1543-0790, 09/2017, Volume 15, Issue 9, p. 651
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
18. Full Text Take back the research
by Kahl, Brad S
Clinical Advances in Hematology and Oncology, ISSN 1543-0790, 08/2017, Volume 15, Issue 8, p. 567
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
19. Full Text Letter From the Editor: Take back the research
by Kahl, Brad S
Clinical advances in hematology & oncology : H&O, ISSN 1543-0790, 08/2017, Volume 15, Issue 8, p. 567
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
20. Full Text ASCO cage match: BR vs R-CHOP
by Kahl, Brad S
Clinical Advances in Hematology and Oncology, ISSN 1543-0790, 07/2017, Volume 15, Issue 7, p. 502
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.